Evidence map›Paper›PMID 28027345›Full record

ArticleJAMA pediatrics2017

Association of State Recreational Marijuana Laws With Adolescent Marijuana Use.

Magdalena Cerdá, Melanie Wall, Tianshu Feng, Katherine M Keyes, Aaron Sarvet, John Schulenberg, Patrick M O'Malley, Rosalie Liccardo Pacula, Sandro Galea, Deborah S Hasin

Abstract read
In one paragraph

Article in JAMA pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 176 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

176 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Difference-in-differences analysis with repeated cross-sectional survey data.Health services & outcomes research methodology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Magdalena CerdáDepartment of Emergency Medicine, University of California Davis School of Medicine, Sacramento.
Melanie WallDepartment of Psychiatry, Columbia University Medical Center, New York, New York3New York State Psychiatric Institute, New York4Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York.
Tianshu FengDepartment of Psychiatry, Columbia University Medical Center, New York, New York5Research Foundation of Mental Hygiene, New York, New York.
Katherine M KeyesDepartment of Psychiatry, Columbia University Medical Center, New York, New York6Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Aaron SarvetDepartment of Psychiatry, Columbia University Medical Center, New York, New York3New York State Psychiatric Institute, New York6Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
John SchulenbergDepartment of Psychology, University of Michigan, Ann Arbor8Institute for Social Research, University of Michigan, Ann Arbor.
Patrick M O'MalleyInstitute for Social Research, University of Michigan, Ann Arbor.
Rosalie Liccardo PaculaRAND Corporation, Santa Monica, California.
Sandro GaleaBoston School of Public Health, Boston University, Boston, Massachusetts.
Deborah S HasinDepartment of Psychiatry, Columbia University Medical Center, New York, New York3New York State Psychiatric Institute, New York6Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

Funding

Monitoring the Future: Drug Use & Lifestyles of American Youth (Supp1: Nicotine Pouch and E-cigarette Use Among US Adolescents: National Estimates of Brand Use and Flavor Preferences)R01DA001411 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Richard A Miech · 1985 to 2026
$144.9M
State medical marijuana laws and MTF teen marijuana use and attitudes since 1991R01DA034244 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2012 to 2016
$3.0M
Health and social consequences of national marijuana legalizationR01DA040924 · NIDA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CERDA, MAGDALENA · 2016 to 2019
$1.3M
Race, alcohol consumption and vehicle crashes: an epidemiologic paradoxK01AA021511 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KEYES, KATHERINE M. · 2013 to 2017
$904k
Trajectories of Substance Use and Comorbid Mental IllnessK01DA030449 · NIDA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CERDA, MAGDALENA · 2011 to 2015
$897k
NIAAA NIH HHS K01 AA021511NIDA NIH HHS K01 DA030449NIDA NIH HHS R01 DA001411NIDA NIH HHS R01 DA034244NIDA NIH HHS R01 DA040924
6 · The paper itself

Abstract

Importance: Historical shifts are occurring in marijuana policy. The effect of legalizing marijuana for recreational use on rates of adolescent marijuana use is a topic of considerable debate. Objective: To examine the association between the legalization of recreational marijuana use in Washington and Colorado in 2012 and the subsequent perceived harmfulness and use of marijuana by adolescents. Design, Setting, and Participants: We used data of 253 902 students in eighth, 10th, and 12th grades from 2010 to 2015 from Monitoring the Future, a national, annual, cross-sectional survey of students in secondary schools in the contiguous United States. Difference-in-difference estimates compared changes in perceived harmfulness of marijuana use and in past-month marijuana use in Washington and Colorado prior to recreational marijuana legalization (2010-2012) with postlegalization (2013-2015) vs the contemporaneous trends in other states that did not legalize recreational marijuana use in this period. Main Outcomes and Measures: Perceived harmfulness of marijuana use (great or moderate risk to health from smoking marijuana occasionally) and marijuana use (past 30 days). Results: Of the 253 902 participants, 120 590 of 245 065(49.2%) were male, and the mean (SD) age was 15.6 (1.7) years. In Washington, perceived harmfulness declined 14.2% and 16.1% among eighth and 10th graders, respectively, while marijuana use increased 2.0% and 4.1% from 2010-2012 to 2013-2015. In contrast, among states that did not legalize recreational marijuana use, perceived harmfulness decreased by 4.9% and 7.2% among eighth and 10th graders, respectively, and marijuana use decreased by 1.3% and 0.9% over the same period. Difference-in-difference estimates comparing Washington vs states that did not legalize recreational drug use indicated that these differences were significant for perceived harmfulness (eighth graders: % [SD], -9.3 [3.5]; P = .01; 10th graders: % [SD], -9.0 [3.8]; P = .02) and marijuana use (eighth graders: % [SD], 5.0 [1.9]; P = .03; 10th graders: % [SD], 3.2 [1.5]; P = .007). No significant differences were found in perceived harmfulness or marijuana use among 12th graders in Washington or for any of the 3 grades in Colorado. Conclusions and Relevance: Among eighth and 10th graders in Washington, perceived harmfulness of marijuana use decreased and marijuana use increased following legalization of recreational marijuana use. In contrast, Colorado did not exhibit any differential change in perceived harmfulness or past-month adolescent marijuana use following legalization. A cautious interpretation of the findings suggests investment in evidence-based adolescent substance use prevention programs in any additional states that may legalize recreational marijuana use.

Indexed as

Adolescent BehaviorAdolescentColoradoCross-Sectional StudiesFemaleHumansLegislation, DrugMaleMarijuana AbuseMarijuana SmokingPublic PolicyUnited StatesWashington

Identifiers

PMID28027345
PMCPMC5365078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.